Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan S Jick

Showing results (31-40 of 184) with videos related to

Pageof 19
Sort By:
Journal of the American Academy of Dermatology|May 3, 2011
Statin use and risk of first-time psoriasis diagnosisYolanda B Brauchli, Susan S Jick, Christoph R Meier
British Journal of Clinical Pharmacology|March 13, 2003
Who receives lipid-lowering drugs: the effects of comorbidities and patient characteristics on treatment initiationChen-Chang Yang, Susan S Jick, Marcia A Testa
British Journal of Clinical Pharmacology|July 10, 2003
Discontinuation and switching of therapy after initiation of lipid-lowering drugs: the effects of comorbidities and patient characteristicsChen-Chang Yang, Susan S Jick, Marcia A Testa
Pediatrics|August 3, 2004
Inhaled corticosteroids and the risk of fractures in children and adolescentsRaymond G Schlienger, Susan S Jick, Christoph R Meier
Contraception|April 20, 2010
ORTHO EVRA and venous thromboembolism: an updateSusan S Jick, Katrina W Hagberg, James A Kaye
Drug Safety|January 19, 2022
β-Blockers and the Risk of Depression: A Matched Case-Control StudyDelia Bornand, Daphne Reinau, Susan S Jick, et al.
Journal of the American Geriatrics Society|March 31, 2012
Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control studyPatrick Imfeld, Michael Bodmer, Susan S Jick, et al.
Chest|October 6, 2009
COPD and the risk of depressionCornelia Schneider, Susan S Jick, Ulrich Bothner, et al.
Pharmacotherapy|September 27, 2006
Nonsteroidal antiinflammatory drugs and acute myocardial infarction in patients with no major risk factorsHershel Jick, James A Kaye, Stefan Russmann, et al.
Clinical Epidemiology|June 30, 2016
Doubling of serum creatinine and the risk of cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes mellitus: a cohort studyCornelia Schneider, Blai Coll, Susan S Jick, et al.
Pageof 19

Showing results (31-40 of 184) with videos related to

Sort By:
Pageof 19
Journal of the American Academy of Dermatology|May 3, 2011
Statin use and risk of first-time psoriasis diagnosisYolanda B Brauchli, Susan S Jick, Christoph R Meier
British Journal of Clinical Pharmacology|March 13, 2003
Who receives lipid-lowering drugs: the effects of comorbidities and patient characteristics on treatment initiationChen-Chang Yang, Susan S Jick, Marcia A Testa
British Journal of Clinical Pharmacology|July 10, 2003
Discontinuation and switching of therapy after initiation of lipid-lowering drugs: the effects of comorbidities and patient characteristicsChen-Chang Yang, Susan S Jick, Marcia A Testa
Pediatrics|August 3, 2004
Inhaled corticosteroids and the risk of fractures in children and adolescentsRaymond G Schlienger, Susan S Jick, Christoph R Meier
Contraception|April 20, 2010
ORTHO EVRA and venous thromboembolism: an updateSusan S Jick, Katrina W Hagberg, James A Kaye
Drug Safety|January 19, 2022
β-Blockers and the Risk of Depression: A Matched Case-Control StudyDelia Bornand, Daphne Reinau, Susan S Jick, et al.
Journal of the American Geriatrics Society|March 31, 2012
Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control studyPatrick Imfeld, Michael Bodmer, Susan S Jick, et al.
Chest|October 6, 2009
COPD and the risk of depressionCornelia Schneider, Susan S Jick, Ulrich Bothner, et al.
Pharmacotherapy|September 27, 2006
Nonsteroidal antiinflammatory drugs and acute myocardial infarction in patients with no major risk factorsHershel Jick, James A Kaye, Stefan Russmann, et al.
Clinical Epidemiology|June 30, 2016
Doubling of serum creatinine and the risk of cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes mellitus: a cohort studyCornelia Schneider, Blai Coll, Susan S Jick, et al.
Pageof 19